Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves Cyramza for hepatocellular carcinoma previously treated with sorafenib

May 13, 2019

AVXS-201 gene therapy is effective in reducing symptoms in Rett syndrome murine models

May 13, 2019

Transgene's IND cleared for initiation of phase I study of TG-4050 in ovarian cancer

May 13, 2019

Esteve Pharmaceuticals synthesizes new dual CACNA2D1/NET ligands

May 13, 2019

Amgen patents short transient receptor potential channel 6 antagonists

May 13, 2019

New broad spectrum antivirals discovered at FORGE Life Science

May 13, 2019

Polyphor temporarily halts enrollment in phase III studies of murepavadin

May 13, 2019

Gene editing restores skin functionality in blistering disease

May 13, 2019

SHR-1210 plus capecitabine and oxaliplatin shows promising safety and efficacy in GC/GEJ

May 13, 2019

Investigators present phase II data for CBT-001 for the treatment of pterygia

May 13, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...